EKF Diagnostics (LON:EKF) Stock Price Up 12.3% – Time to Buy?

EKF Diagnostics Holdings plc (LON:EKF)’s share price traded up 12.3% during mid-day trading on Tuesday . The stock traded as high as GBX 23.77 ($0.31) and last traded at GBX 23.02 ($0.30). 3,099,554 shares changed hands during mid-day trading, an increase of 555% from the average session volume of 473,495 shares. The stock had previously closed at GBX 20.50 ($0.26).

EKF Diagnostics Stock Up 12.3 %

The firm’s 50 day simple moving average is GBX 23.35 and its 200-day simple moving average is GBX 25.91. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The company has a market cap of £102.30 million, a price-to-earnings ratio of 21.42 and a beta of 0.57.

EKF Diagnostics (LON:EKF) last announced its earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. As a group, sell-side analysts anticipate that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.